BridgeMD
Compares treatment options for Hip Dysplasia
Official title Exercise and Patient Education Compared With Usual Care in Patients With Hip Dysplasia
ClinicalTrials.gov ID: NCT04795843
What this study is testing
- What it's testing
- This effectiveness trial will investigate if patients with hip dysplasia randomised to exercise and patient education have a different mean change in self-reported pain measured by the Copenhagen Hip and Groin Outcome Score (HAGOS) compared with those randomised to usual care over a six-month follow-up period. Participating patients will be allocated to either exercise and patient education or usual care.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Radiographically verified hip dysplasia by a Wiberg's centre edge (CE) angle of 10-25 degrees and an acetabular Index (AI) angle \>10 degrees
- Hip and/or groin pain as primary pain for at least three months
- Candidate for periacetabular osteotomy (PAO) but unwilling to undergo PAO, or on a waiting list for surgery (PAO) for 12 months or longer
- Not candidate for PAO (negative impingement test, BMI \>25, hip osteoarthritis, age \>45 years or reduced hip range of motion)
You likely can't join if
- Self-reported pain score \>80 points measured with Copenhagen Hip and Groin outcome score
- Any major planned surgery (i.e. arthroplastic surgery or discectomy surgery)
- BMI \>35
- Acetabular retroversion defined by crossover sign and posterior wall sign
- Calvé Legg Perthes or epiphysiolysis
- Previous pelvic/hip surgery in index limb
See the full eligibility criteria
- Radiographically verified hip dysplasia by a Wiberg's centre edge (CE) angle of 10-25 degrees and an acetabular Index (AI) angle \>10 degrees
- Hip and/or groin pain as primary pain for at least three months
- Candidate for periacetabular osteotomy (PAO) but unwilling to undergo PAO, or on a waiting list for surgery (PAO) for 12 months or longer
- Not candidate for PAO (negative impingement test, BMI \>25, hip osteoarthritis, age \>45 years or reduced hip range of motion)
- Self-reported pain score \>80 points measured with Copenhagen Hip and Groin outcome score
- Any major planned surgery (i.e. arthroplastic surgery or discectomy surgery)
- BMI \>35
- Acetabular retroversion defined by crossover sign and posterior wall sign
- Calvé Legg Perthes or epiphysiolysis
- Previous pelvic/hip surgery in index limb
- Previous pelvic/hip surgery within the last 2 years in contralateral limb
- Previous surgery due to herniated disc or spondylodesis
- Previous arthroplastic surgery in the hip, knee or ankle
- Physical (pregnancy/trauma), neurological, medical or rheumatic conditions severely affecting the hip function
- Inadequacy in written and spoken Danish, mental illness or other conditions affecting the ability to follow mandatory procedures for participation
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus N, Denmark
- Silkeborg, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus N, Denmark; Silkeborg, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.